Biotech Values

[bladerunner1717]

re: JAV

Thanks, apljack. Has Morgan revised its analysis and/or targets. (Well, it HAS to adjust its target, since May, 2008 has come and gone.)

In loking at the company's cash position, I don't see how they would have enough cash to estabish a sales force, even if a modest one, and runa amarketing campaign. Didn't they think of that before this? It seems like a mid-level pain company--Endo? Purdue? Cephalon?--would be interested. What do you think is holding up a partnership? (Does the company provide any hints here?) Do you think they should still try to go it alone?

Do you view the stock as a "buy" here?


Bladerunner